Medtronic Price to Sales Ratio 2010-2025 | MDT
Historical PS ratio values for Medtronic (MDT) over the last 10 years. The current P/S ratio for Medtronic as of May 30, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Medtronic P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-30 | 82.98 | 3.25 | |
| 2025-01-31 | 90.11 | $25.54 | 3.53 |
| 2024-10-31 | 87.79 | $25.17 | 3.49 |
| 2024-07-31 | 78.39 | $24.63 | 3.18 |
| 2024-04-30 | 77.62 | $24.30 | 3.19 |
| 2024-01-31 | 83.98 | $24.25 | 3.46 |
| 2023-10-31 | 67.13 | $23.98 | 2.80 |
| 2023-07-31 | 82.79 | $23.68 | 3.50 |
| 2023-04-30 | 85.13 | $23.43 | 3.63 |
| 2023-01-31 | 77.67 | $23.00 | 3.38 |
| 2022-10-31 | 80.34 | $22.95 | 3.50 |
| 2022-07-31 | 84.43 | $23.05 | 3.66 |
| 2022-04-30 | 94.51 | $23.41 | 4.04 |
| 2022-01-31 | 93.16 | $23.47 | 3.97 |
| 2021-10-31 | 107.22 | $23.46 | 4.57 |
| 2021-07-31 | 116.88 | $23.33 | 5.01 |
| 2021-04-30 | 115.95 | $22.26 | 5.21 |
| 2021-01-31 | 98.11 | $20.65 | 4.75 |
| 2020-10-31 | 88.19 | $20.62 | 4.28 |
| 2020-07-31 | 84.12 | $20.67 | 4.07 |
| 2020-04-30 | 84.57 | $21.39 | 3.95 |
| 2020-01-31 | 99.38 | $22.96 | 4.33 |
| 2019-10-31 | 93.30 | $22.82 | 4.09 |
| 2019-07-31 | 86.90 | $22.62 | 3.84 |
| 2019-04-30 | 75.29 | $22.48 | 3.35 |
| 2019-01-31 | 74.53 | $22.44 | 3.32 |
| 2018-10-31 | 75.31 | $22.30 | 3.38 |
| 2018-07-31 | 75.27 | $21.96 | 3.43 |
| 2018-04-30 | 66.46 | $21.93 | 3.03 |
| 2018-01-31 | 70.82 | $21.67 | 3.27 |
| 2017-10-31 | 66.02 | $21.49 | 3.07 |
| 2017-07-31 | 68.44 | $21.60 | 3.17 |
| 2017-04-30 | 67.38 | $21.32 | 3.16 |
| 2017-01-31 | 61.32 | $20.94 | 2.93 |
| 2016-10-31 | 65.76 | $20.55 | 3.20 |
| 2016-07-31 | 69.91 | $20.21 | 3.46 |
| 2016-04-30 | 62.83 | $20.19 | 3.11 |
| 2016-01-31 | 59.97 | $21.47 | 2.79 |
| 2015-10-31 | 58.10 | $20.93 | 2.78 |
| 2015-07-31 | 61.28 | $20.38 | 3.01 |
| 2015-04-30 | 57.90 | $19.57 | 2.96 |
| 2015-01-31 | 55.31 | $17.49 | 3.16 |
| 2014-10-31 | 52.58 | $17.27 | 3.04 |
| 2014-07-31 | 47.40 | $17.03 | 2.78 |
| 2014-04-30 | 44.94 | $16.78 | 2.68 |
| 2014-01-31 | 43.02 | $16.62 | 2.59 |
| 2013-10-31 | 43.44 | $16.44 | 2.64 |
| 2013-07-31 | 41.59 | $16.27 | 2.56 |
| 2013-04-30 | 34.95 | $16.13 | 2.17 |
| 2013-01-31 | 34.70 | $15.85 | 2.19 |
| 2012-10-31 | 30.78 | $15.60 | 1.97 |
| 2012-07-31 | 29.00 | $15.40 | 1.88 |
| 2012-04-30 | 27.92 | $15.22 | 1.83 |
| 2012-01-31 | 28.02 | $14.84 | 1.89 |
| 2011-10-31 | 25.08 | $14.73 | 1.70 |
| 2011-07-31 | 25.82 | $14.54 | 1.78 |
| 2011-04-30 | 29.72 | $14.32 | 2.08 |
| 2011-01-31 | 27.12 | $14.04 | 1.93 |
| 2010-10-31 | 24.78 | $13.94 | 1.78 |
| 2010-07-31 | 25.83 | $13.79 | 1.87 |
| 2010-04-30 | 30.34 | $13.86 | 2.19 |
| 2010-01-31 | 29.65 | $13.86 | 2.14 |
| 2009-10-31 | 24.56 | $13.50 | 1.82 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $106.425B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.407B | 27.95 |
| Boston Scientific (BSX) | United States | $155.727B | 38.99 |
| Stryker (SYK) | United States | $146.049B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $127.608B | 0.00 |
| Haleon (HLN) | United Kingdom | $51.105B | 29.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.009B | 0.00 |
| ResMed (RMD) | United States | $35.893B | 26.96 |
| GE HealthCare Technologies (GEHC) | United States | $32.299B | 15.34 |
| Agilent Technologies (A) | United States | $31.909B | 20.73 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Insulet (PODD) | United States | $22.874B | 89.79 |
| Koninklijke Philips (PHG) | Netherlands | $21.656B | 15.57 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.236B | 11.71 |
| Baxter (BAX) | United States | $15.652B | 11.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.683B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.175B | 21.49 |
| Lantheus Holdings (LNTH) | United States | $5.228B | 13.19 |
| Prestige Consumer Healthcare (PBH) | United States | $4.233B | 18.91 |
| Perrigo (PRGO) | Ireland | $3.680B | 9.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.319B | 24.48 |
| Haemonetics (HAE) | United States | $3.253B | 14.82 |
| Envista Holdings (NVST) | United States | $3.097B | 25.73 |
| GN Store Nord (GNNDY) | Denmark | $2.224B | 18.42 |
| QuidelOrtho (QDEL) | United States | $2.074B | 14.27 |
| LeMaitre Vascular (LMAT) | United States | $1.857B | 41.51 |
| AtriCure (ATRC) | United States | $1.711B | 0.00 |
| Acuren (TIC) | United States | $1.276B | 0.00 |
| Neogen (NEOG) | United States | $1.272B | 16.28 |
| AdaptHealth (AHCO) | United States | $1.212B | 12.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.156B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.109B | 24.95 |
| BioLife Solutions (BLFS) | United States | $1.039B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.990B | 12.65 |
| InMode (INMD) | Israel | $0.927B | 9.34 |
| CeriBell (CBLL) | United States | $0.608B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.573B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Owens & Minor (OMI) | United States | $0.510B | 4.23 |
| Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.428B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.62 |
| Aurora Cannabis (ACB) | Canada | $0.298B | 53.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.17 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| ZimVie (ZIMV) | United States | $0.255B | 11.57 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.243B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.229B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.224B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Quanterix (QTRX) | United States | $0.202B | 0.00 |
| Brainsway (BWAY) | Israel | $0.193B | 51.00 |
| Biote (BTMD) | United States | $0.189B | 5.32 |
| TriSalus Life Sciences (TLSI) | United States | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Omeros (OMER) | United States | $0.181B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.57 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 0.00 |
| Jin Medical (ZJYL) | China | $0.118B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Agape ATP (ATPC) | $0.087B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.029B | 38.86 |
| Safety Shot (SHOT) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |